BLVRA and metabolic dysfunction-associated steatotic liver disease: We acknowledge that the design of our study does not allow us to establish a causal nexus between lower VAT BVR-A mRNA expression and increased VAT dysfunction and NAFLD development and thus further studies are warranted to fully understand the pathophysiologic processes behind our observations.